1-2 of 2
Bahru Habtemariam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Robust HbF induction and improvement of anemia and hemolysis with base editing in sickle cell disease: Safety and efficacy findings from the ongoing BEACON study

Free
Ashish Gupta, Akshay Sharma, Haydar Frangoul, Julie Kanter, Markus Mapara, Jignesh Dalal, Asif Alavi, Jennifer Jaroscak, Ernesto Ayala, John DiPersio, Edward D. Ziga, Mary Eapen, Stacey Rifkin-Zenenberg, Srikanth Ambati, Yinzhong Chen, Sarah Chesler, Marcelyne Joseney-Antoine, Leanne Ianniello, Bahru Habtemariam, Priya Chockalingam, Ling Lin, Sunita Goyal, Amy Simon, Alexis Thompson, Matthew Heeney
Journal: Blood
Blood (2025) 146 (Supplement 1): 2532.
https://doi.org/10.1182/blood-2025-2532
Published: 2025
Journal Articles

Enhanced CD34+ cell mobilizations, collections, and comparable safety profile with fixed-dose versus weight-based plerixafor dosing in patients with sickle cell disease receiving autologous CD34+ base-edited hematopoietic stem cells (BEAM-101) in the ongoing BEACON study

Free
Haydar Frangoul, Bahru Habtemariam, Arthur Lo, Srikanth Ambati, Yinzhong Chen, Sarah Chesler, Jigar Patel, Sunita Goyal, Amy Simon, Ashish Gupta
Journal: Blood
Blood (2025) 146 (Supplement 1): 1049.
https://doi.org/10.1182/blood-2025-1049
Published: 2025